48,830
edits
Difference between revisions of "MOC31"
Jump to navigation
Jump to search
→Positive
| Line 11: | Line 11: | ||
*[[Liver metastases]].<ref name=pmid10937059/> | *[[Liver metastases]].<ref name=pmid10937059/> | ||
*[[Lung adenocarcinoma]].<ref name=pmid9490276>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. | journal = Hum Pathol | volume = 29 | issue = 2 | pages = 166-9 | month = Feb | year = 1998 | doi = | PMID = 9490276 }}</ref> | *[[Lung adenocarcinoma]].<ref name=pmid9490276>{{Cite journal | last1 = Ordóñez | first1 = NG. | title = Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. | journal = Hum Pathol | volume = 29 | issue = 2 | pages = 166-9 | month = Feb | year = 1998 | doi = | PMID = 9490276 }}</ref> | ||
*[[Invasive ductal carcinoma of the breast]].<ref name=pmid19391212>{{Cite journal | last1 = Pai | first1 = RK. | last2 = West | first2 = RB. | title = MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study. | journal = Appl Immunohistochem Mol Morphol | volume = 17 | issue = 3 | pages = 202-6 | month = May | year = 2009 | doi = | PMID = 19391212 }}</ref> | |||
*[[Invasive lobular carcinoma]].<ref name=pmid19391212/> | |||
==See also== | ==See also== | ||